RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 164 filers reported holding RELAY THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $8,948,000 | +33.6% | 400,000 | 0.0% | 0.16% | +25.0% |
Q2 2022 | $6,700,000 | -61.2% | 400,000 | -20.0% | 0.13% | -55.9% |
Q1 2021 | $17,285,000 | -16.8% | 500,000 | 0.0% | 0.30% | -16.5% |
Q4 2020 | $20,780,000 | -2.4% | 500,000 | 0.0% | 0.36% | +18.2% |
Q3 2020 | $21,295,000 | – | 500,000 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 4,068,574 | $68,149,000 | 5.76% |
SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $467,408,000 | 3.71% |
BVF INC/IL | 4,384,805 | $73,445,000 | 3.55% |
Boxer Capital, LLC | 2,669,132 | $44,708,000 | 2.83% |
Nextech Invest Ltd. | 475,485 | $7,964,000 | 2.69% |
EcoR1 Capital, LLC | 3,723,541 | $62,369,000 | 2.15% |
HARBOURVEST PARTNERS LLC | 296,402 | $4,965,000 | 1.63% |
Integral Health Asset Management, LLC | 436,262 | $7,307,000 | 1.50% |
Alphabet Inc. | 1,568,753 | $26,277,000 | 1.43% |
Fernwood Investment Management, LLC | 185,063 | $3,100,000 | 1.34% |